Malignant Neoplasm of Unknown Primary
NCI Definition: The spread of a malignant neoplasm from an unknown primary to another region remote from the primary site. 
There is 1 clinical trial for malignant neoplasm of unknown primary, of which 1 is open and 0 are completed or closed. Of the trial that contains malignant neoplasm of unknown primary as an inclusion criterion, 1 is phase 2 (1 open).
Nilotinib and paclitaxel are the most common interventions in malignant neoplasm of unknown primary clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.